• Decrease font size
  • Return font size to normal
  • Increase font size
U.S. Department of Health and Human Services

MAUDE Adverse Event Report: ABBOTT DIAGNOSTICS SCARBOROUGH, INC. ID NOW COVID-19 ASSAY; MOLECULAR IVD FOR ID NOW COVID-19,

  • Print
  • Share
  • E-mail
-
Super Search Devices@FDA
510(k) | DeNovo | Registration & Listing | Adverse Events | Recalls | PMA | HDE | Classification | Standards
CFR Title 21 | Radiation-Emitting Products | X-Ray Assembler | Medsun Reports | CLIA | TPLC
 

ABBOTT DIAGNOSTICS SCARBOROUGH, INC. ID NOW COVID-19 ASSAY; MOLECULAR IVD FOR ID NOW COVID-19, Back to Search Results
Catalog Number 190-000
Device Problem Use of Device Problem (1670)
Patient Problem No Clinical Signs, Symptoms or Conditions (4582)
Event Type  Injury  
Manufacturer Narrative
The remainder of the investigation remains in progress.A supplemental report will be provided after completion.
 
Event Description
The customer reported an increase of invalid results with the id now covid-19 assay for multiple patients over various dates.This mfr.Report is one of four and addresses invalids which occurred in (b)(6).The customer reported twenty-two invalid results with the id now covid-19 assay on direct tested nasopharyngeal and nasal swabs (miraclean technology) for the month of (b)(6).Repeat testing also generated invalid results which resulted in a 1.5 hour delay as the sample had to be recollected for testing using the cepheid platform (results not provided).Per the customer, no patient harm occurred; however, the patients could not be admitted until the test results were back.Additionally, per the customer the delay impacted the entire hospital due to delays in freeing bed space.
 
Manufacturer Narrative
This supplemental report is being submitted to correct the lot number and to provide the investigation conclusion.The case provided two lot numbers (lot m159709 and lot 1034333).However, the customer did not specify which lot was used.The investigations for both lot numbers are being provided.Please see updates: d4, g3, g6, h2 and h6.Testing was performed at abbott diagnostics scarborough, inc.On retained kit lot m159709 with internal positive quality control samples and negative quality control swabs.All test results were valid and performed as expected.Additionally, the manufacturing records and quality control release testing was reviewed for test kit part number190-000 / lot m159709.Test base part number 190-430 / lot m159709.The lot met the required release specifications.A review of the complaints reported as false positive patient results (confirmed and unconfirmed, conflicting results) related to kit lot m159709 showed that the complaint rate is (b)(4).The exipiration date: (lot m159709) 11/11/2021 and (lot 1034333) 11/09/2021.The manufacturer date: (lot m159709) 5/14/2021 and (lot 1034333) 5/17/2021.Testing was performed at abbott diagnostics scarborough, inc.On retained kit lot 1034333 with internal positive quality control samples and negative quality control swabs.All test results were valid and performed as expected.Additionally, the manufacturing records and quality control release testing was reviewed for test kit part number 190-000 / lot 1034333.Test base part number 190-430 / lot 1034333.The lot met the required release specifications.A review of the complaints reported as false positive patient results (confirmed and unconfirmed, conflicting results) related to kit lot 1034333 showed that the complaint rate is (b)(4).In conclusion, abbott diagnostics scarborough was unable to determine the exact root cause of the reported issue however a possible assignable root cause is sample interference.Abbott scarborough diagnostics was able to determine from the logfile that the majority of the invalid results were due to unknown sample interference.Substances in the sample itself may have interfered with the reaction.It was also observed that some of the invalids were also due to sample transfer errors.Based on the above summary, the investigation is deemed closed.The product will continue to be monitored and tracked.
 
Search Alerts/Recalls

  New Search  |  Submit an Adverse Event Report

Brand Name
ID NOW COVID-19 ASSAY
Type of Device
MOLECULAR IVD FOR ID NOW COVID-19,
Manufacturer (Section D)
ABBOTT DIAGNOSTICS SCARBOROUGH, INC.
10 southgate road
scarborough,
ME 04074
Manufacturer Contact
erina marshall
10 southgate road
scarborough,
MDR Report Key12380652
MDR Text Key268912690
Report Number1221359-2021-02454
Device Sequence Number1
Product Code QJR
Combination Product (y/n)N
Reporter Country CodeUS
PMA/PMN Number
EUA2000074
Number of Events Reported1
Summary Report (Y/N)N
Report Source Manufacturer
Source Type Health Professional
Reporter Occupation Other
Type of Report Initial,Followup
Report Date 03/25/2022
1 Device was Involved in the Event
1 Patient was Involved in the Event
Is this an Adverse Event Report? Yes
Is this a Product Problem Report? No
Device Operator Health Professional
Device Catalogue Number190-000
Was Device Available for Evaluation? No
Is the Reporter a Health Professional? No
Initial Date Manufacturer Received 08/03/2021
Initial Date FDA Received08/27/2021
Supplement Dates Manufacturer Received11/29/2021
Supplement Dates FDA Received03/25/2022
Was Device Evaluated by Manufacturer? No
Date Device Manufactured02/02/2021
Is the Device Single Use? Yes
Is This a Reprocessed and Reused Single-Use Device? No
Type of Device Usage Initial
Patient Sequence Number1
Patient Outcome(s) Other;
-
-